BRAF and melanoma: Importantly, taking into account that vanicoside A and B could harm melanoma cell lines by the oxidative death mechanism, it could be supposed that they could also influence non-mutated cell lines (with the wild-type of the BRAF gene) which significantly expands their potential therapeutic range.